Login to Your Account

Midatech Raises $9.7M to Fund Nano-based Insulin Candidate

By Nuala Moran
BioWorld International Correspondent

Wednesday, January 11, 2012
LONDON – Nanomedicine specialist Midatech Ltd. closed a £6.3 million (US$9.7 million) funding round as it confirmed the formal launch of its joint venture with MonoSol Rx, in which the two partners will develop a gold nanoparticle-based formulation of insulin, designed to be delivered via a patch that adheres to the inside of the mouth.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription